product · release 2026-09-20
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Printed organisms · observed
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| L. acidophilus W22 | Lactobacillus acidophilus | W22 | not printed | not printed | T3; observed; quantity unavailable |
| L. brevis W63 | Lactobacillus brevis | W63 | not printed | not printed | T3; observed; quantity unavailable |
| L. casei W56 | Lacticaseibacillus casei | W56 | not printed | not printed | T3; observed; quantity unavailable |
| Lactobacillus helveticus W74 | Lactobacillus helveticus | W74 | not printed | not printed | T3; observed; quantity unavailable |
| L. pentosus W2 (KCA1) | Lactobacillus pentosus | W2 | not printed | not printed | T3; observed; quantity unavailable |
| L. plantarum W21 | Lactiplantibacillus plantarum | W21 | not printed | not printed | T3; observed; quantity unavailable |
| L. salivarius W24 | Ligilactobacillus salivarius | W24 | not printed | not printed | T3; observed; quantity unavailable |
Pack, dose and cost
Printed potency
No numeric quantity is printed on 7 organism rows of the latest observed label; potency basis The potency basis is not stated. 7 rows sit inside a proprietary blend, so their individual amounts are not disclosed.
Evidence behind the label
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Lacticaseibacillus casei | 240 |
| Lacticaseibacillus casei W56 | 5 |
| Lactiplantibacillus plantarum | 267 |
| Lactiplantibacillus plantarum W21 | 0 |
| Lactobacillus acidophilus | 381 |
| Lactobacillus acidophilus W22 | 1 |
| Lactobacillus brevis | 36 |
| Lactobacillus brevis W63 | 6 |
| Lactobacillus helveticus | 59 |
| Ligilactobacillus salivarius | 63 |
| Ligilactobacillus salivarius W24 | 6 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
This formulation scores above 11.8% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
| Other products carrying the same strain | Shared strain | Gut Index Score | Observed price |
|---|---|---|---|
| North American Herb & Spice Health-Bac | W22 | 65.90 | not observed |
| Physician's Strength Potent-Bac | W22 | 65.90 | not observed |
| Invivo Bio.Me Barrier | W56 | 72.78 | not observed |
Axes 1–2
Evidence queries are incomplete. A2 uses the known matching records as a lower bound.
Scored using the available matching evidence. Identity: A commercial strain code is printed. Quantity disclosure: 0.0%. Potency: The potency basis is not stated.
Axes 3–4
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
undefined: no permitted price observation in this release
Sensitivity
Preference interval 40.49–50.17; rank uncertainty 2834.00–3067.00; rank class 4.
Versions
Preference tool
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Brand: Invivo — every published product of this brand, its potency basis and its observed reformulations.
Elsewhere in this release
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Ivitskiy, I. (2026). Invivo Bio.Me Femme UT. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/bio-me-femme-ut/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Invivo Bio.Me Femme UT: 7 of 7 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 259862. Window: NIH DSLD snapshot Sep 2026.
7 / 7 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Invivo Bio.Me Femme UT: 0 of 1 observed label snapshots state a potency basis; latest basis is not stated. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Invivo Bio.Me Femme UT: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 49.20 on the 100-point scale; rank class 4 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Invivo Bio.Me Femme UT has 1 observed versions across 1 formulation groups; last recorded edge type: same product. Window: NIH DSLD snapshot Sep 2026.
1 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Invivo Bio.Me Femme UT: 0 of 1 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437